Research Article

The Abundance of Plasmid-Mediated Quinolone Resistance Genes in Enterobacter cloacae Strains Isolated from Clinical Specimens in Kermanshah, Iran

Table 3

Association between antibiotic resistance in ESBL-positive and ESBL-negative E. cloacae isolates.

AntibioticTotal resistance no (%)ESBL-positive 65 isolatesESBL-negative 48 isolates-value
RISRISRIS

NA68 (60.2)4 (3.5)41 (36.3)49 (75.4)2 (3.1)14 (21.5)19 (39.6)2 (4.2)27 (56.2)0.001
CIP66 (58.4)8 (7.1)39 (34.5)47 (72.3)5 (7.7)13 (20)19 (39.6)3 (6.2)26 (54.2)0.001
NOR56 (49.6)8 (7.1)49 (43.4)39 (60)4 (6.2)22 (33.8)17 (35.4)4 (8.4)27 (56.2)0.83
LEV45 (39.8)3 (2.7)65 (57.5)36 (55.4)029 (44.6)8 (16.6)4 (8.4)36 (75)0.75
GAT38 (33.6)075 (66.4)30 (46.2)035 (53.8)8 (16.6)040 (83.4)0.001
OFX49 (43.4)4 (3.5)60 (53.1)35 (53.8)3 (4.6)27 (41.6)13 (27.1)2 (4.2)33 (68.7)0.013
CTX57 (50.4)056 (49.6)51 (78.5)014 (21.5)6 (12.5)042 (87.5)0.001
CAZ51 (45.1)062 (54.9)51 (78.5)2 (3.1)12 (18.4)2 (4.2)046 (95.8)0.001
CRO63 (55.8)050 (44.2)55 (84.6)010 (15.4)8 (16.6)040 (83.4)0.32
ATM53 (46.9)2 (1.8)58 (51.3)50 (76.9)015 (23.1)1 (2.1)047 (97.9)0.001
GM57 (50.4)2 (1.8)54 (47.8)52 (80)1 (1.6)12 (18.4)5 (10.4)1 (2.1)42 (87.5)0.001
AK44 (38.9)2 (1.8)67 (59.3)41 (63.1)1 (1.6)23 (35.3)3 (6.2)1 (2.1)44 (91.7)0.001
TN66 (58.4)3 (2.7)44 (38.9)38 (58.5)3 (4.6)24 (36.9)28 (58.3)020 (41.7)0.358
IMI16 (14.2)6 (5.3)91 (80.5)10 (15.4)3 (4.6)52 (80)6 (12.5)3 (6.2)39 (81.3)0.270
NI34 (30.1)079 (69.9)23 (35.4)042 (64.6)11 (22.9)037 (77.1)0.155
CO11 (9.7)2 (1.8)100 (88.5)9 (13.8)056 (86.2)2 (4.2)2 (4.2)44 (91.6)0.156
C38 (33.6)075 (66.4)24 (36.9)041 (63.1)14 (29.2)034 (70.8)0.290

R: resistance; S: sensitive; I: intermediate. NA: nalidixic acid; CIP: ciprofloxacin; NOR: norfloxacin; LEV: levofloxacin; GAT: gatifloxacin; OFX: ofloxacin; CTX: cefotaxime; CAZ: ceftazidime; CRO: ceftriaxone; ATM: aztreonam; GM: gentamicin; AK: amikacin; TN: tobramycin; IMI: imipenem; NI: nitrofurantoin; CO: colistin; C: chloramphenicol.